Borderline Resectable Pancreatic Cancer. - Wikidata - awgldk - TriplyDB

Borderline Resectable Pancreatic Cancer.

Borderline Resectable Pancreatic Cancer.

http://www.wikidata.org/entity/Q46839715

about

Borderline Resectable Pancreatic Cancer.

http://www.wikidata.org/entity/Q46839715

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh

2013年學術文章

@zh-hant

name

Borderline Resectable Pancreatic Cancer.

@en

Borderline Resectable Pancreatic Cancer.

@nl

type

label

Borderline Resectable Pancreatic Cancer.

@en

Borderline Resectable Pancreatic Cancer.

@nl

prefLabel

Borderline Resectable Pancreatic Cancer.

@en

Borderline Resectable Pancreatic Cancer.

@nl

P1433

Q46839715-56B5DB49-AD10-408A-8F81-B5E8D79D3AA2

P1476

Q46839715-E82E0AEE-C0EB-4EC2-8247-5DCF26AFCFA5

P2093

Q46839715-1F35081F-A7D2-47AC-8B3D-60706EF2500D

P2860

Q46839715-01AEAE4B-26D3-47E8-A5B7-83827C5DA478

Q46839715-2049488B-4D7A-4460-9B96-479575F280A5

Q46839715-38C50F5B-5158-4228-9147-16D3BC4965E8

Q46839715-40D0337A-AF13-4213-A10C-54DCF927E185

Q46839715-6B46E88D-0DB7-4FB9-ADDA-B774EF9A53BC

Q46839715-A978C024-13FB-47A9-9A5D-CE428A04B3CA

Q46839715-AAA91BBB-968D-46B7-8C5A-89F059F59446

Q46839715-D014257B-6D60-4D4C-A371-22D4DBDAA384

Q46839715-D0EF29B9-42CF-4214-AAFB-FCCC14C20D92

Q46839715-E1FB49D2-8296-4F2A-81C2-97513ACE1196

P304

Q46839715-D37A7B61-5BC8-44B2-9623-AD982EC2756B

P31

Q46839715-CBFB5BFD-D3FD-4219-9D5F-F7FD4B734A4D

P433

Q46839715-AD41FA15-72F3-4327-8700-EF7B44030FBC

P478

Q46839715-0D4884A7-35F3-4E04-AC43-9B0F36A3AB34

P577

Q46839715-CBA19AB2-8C8F-493E-A51A-7B528EC877BC

P932

Q46839715-23AF7C19-E467-49A2-A661-CCB9FEFBA9B5

P1433

Gastrointestinal cancer research : GCR

P1476

Borderline Resectable Pancreatic Cancer.

@en

P2093

Fleming JB

http://www.w3.org/2001/XMLSchema#string

P2860

Preoperative capecitabine and concurrent radiation for borderline resectable pancreatic cancer.

Randomized phase II study of gemcitabine plus radiotherapy versus gemcitabine, 5-fluorouracil, and cisplatin followed by radiotherapy and 5-fluorouracil for patients with locally advanced, potentially resectable pancreatic adenocarcinoma.

Progress for resectable pancreatic [corrected] cancer?: a population-based assessment of US practices.

Borderline resectable pancreatic cancer: definitions, management, and role of preoperative therapy.

Chemoradiation followed by chemotherapy before resection for borderline pancreatic adenocarcinoma.

Combined modality treatment of resectable and borderline resectable pancreas cancer: expert consensus statement.

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement.

Standardization of surgical and pathologic variables is needed in multicenter trials of adjuvant therapy for pancreatic cancer: results from the ACOSOG Z5031 trial.

Defining venous involvement in borderline resectable pancreatic cancer.

Borderline resectable pancreatic cancer: the importance of this emerging stage of disease.

P304

S15-S22

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P433

4 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P932

3849916

http://www.w3.org/2001/XMLSchema#string